Un examen clinique, une échographie Doppler et des tests sanguins sont utilisés.
Thrombose veineuseÉchographie Doppler
#2
Quels tests sanguins sont utilisés ?
Le dosage du D-dimère est courant pour évaluer la présence d'un caillot.
D-dimèreThrombose veineuse
#3
Quels signes cliniques indiquent une thrombose ?
Douleur, gonflement, rougeur et chaleur dans la zone affectée sont des signes clés.
SymptômesThrombose veineuse
#4
L'IRM est-elle utile pour le diagnostic ?
Oui, l'IRM peut aider à visualiser les thromboses dans les veines profondes.
Imagerie par résonance magnétiqueThrombose veineuse
#5
Quand faut-il suspecter une thrombose veineuse ?
En cas de douleur soudaine et de gonflement d'un membre, une évaluation est nécessaire.
Thrombose veineuseÉvaluation clinique
Symptômes
5
#1
Quels sont les symptômes d'une thrombose veineuse ?
Les symptômes incluent douleur, gonflement, rougeur et chaleur au site de la thrombose.
SymptômesThrombose veineuse
#2
La douleur est-elle toujours présente ?
Non, la douleur peut être absente, surtout dans les cas de thrombose asymptomatique.
Thrombose veineuseDouleur
#3
Peut-on avoir de la fièvre avec une thrombose ?
Une légère fièvre peut survenir, mais ce n'est pas un symptôme courant.
FièvreThrombose veineuse
#4
Les symptômes varient-ils selon l'emplacement ?
Oui, les symptômes peuvent différer selon que la thrombose est superficielle ou profonde.
Thrombose veineuseLocalisation
#5
Y a-t-il des symptômes systémiques ?
Des symptômes systémiques comme l'essoufflement peuvent indiquer une embolie pulmonaire.
Embolie pulmonaireThrombose veineuse
Prévention
5
#1
Comment prévenir la thrombose veineuse ?
L'activité physique régulière, l'hydratation et le port de bas de compression aident.
PréventionThrombose veineuse
#2
Les voyages prolongés augmentent-ils le risque ?
Oui, rester assis longtemps peut favoriser la formation de caillots sanguins.
VoyagesThrombose veineuse
#3
Les anticoagulants préventifs sont-ils recommandés ?
Oui, ils sont souvent prescrits aux patients à risque élevé, comme après une chirurgie.
AnticoagulantsPrévention
#4
Quelles sont les recommandations post-chirurgicales ?
Mobilisation précoce et utilisation de bas de compression sont recommandées.
ChirurgieThrombose veineuse
#5
L'obésité est-elle un facteur de risque ?
Oui, l'obésité augmente le risque de thrombose veineuse en raison de la pression sur les veines.
ObésitéThrombose veineuse
Traitements
5
#1
Quels traitements sont disponibles pour la thrombose ?
Les anticoagulants, les bas de compression et parfois la thrombolyse sont utilisés.
AnticoagulantsThrombose veineuse
#2
Les anticoagulants sont-ils toujours nécessaires ?
Oui, ils sont essentiels pour prévenir l'extension du caillot et les complications.
AnticoagulantsThrombose veineuse
#3
Qu'est-ce que la thrombolyse ?
C'est un traitement qui utilise des médicaments pour dissoudre les caillots sanguins.
ThrombolyseThrombose veineuse
#4
Les bas de compression sont-ils efficaces ?
Oui, ils aident à réduire le gonflement et à améliorer la circulation sanguine.
Bas de compressionThrombose veineuse
#5
Quand est-il nécessaire d'hospitaliser un patient ?
L'hospitalisation est nécessaire en cas de thrombose massive ou de complications.
HospitalisationThrombose veineuse
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent l'embolie pulmonaire, le syndrome post-thrombotique et la douleur chronique.
Embolie pulmonaireComplications
#2
Qu'est-ce que le syndrome post-thrombotique ?
C'est une condition chronique causée par des dommages aux veines après une thrombose.
Syndrome post-thrombotiqueThrombose veineuse
#3
L'embolie pulmonaire est-elle grave ?
Oui, c'est une complication potentiellement mortelle nécessitant une intervention rapide.
Embolie pulmonaireComplications
#4
Comment prévenir les complications ?
Un traitement précoce et une surveillance régulière aident à prévenir les complications.
PréventionThrombose veineuse
#5
Les complications sont-elles fréquentes ?
Elles peuvent survenir dans 20 à 30 % des cas de thrombose veineuse profonde non traitée.
ComplicationsThrombose veineuse
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent l'immobilisation, l'obésité, les antécédents familiaux et la chirurgie.
Facteurs de risqueThrombose veineuse
#2
Le tabagisme augmente-t-il le risque ?
Oui, le tabagisme est un facteur de risque connu pour la thrombose veineuse.
TabagismeThrombose veineuse
#3
Les femmes enceintes sont-elles à risque ?
Oui, la grossesse augmente le risque de thrombose en raison des changements hormonaux.
GrossesseThrombose veineuse
#4
L'âge est-il un facteur de risque ?
Oui, le risque de thrombose augmente avec l'âge, surtout après 60 ans.
ÂgeThrombose veineuse
#5
Les maladies chroniques influencent-elles le risque ?
Oui, des conditions comme le cancer et les maladies cardiaques augmentent le risque.
Maladies chroniquesThrombose veineuse
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thrombose veineuse : Questions médicales les plus fréquentes",
"headline": "Thrombose veineuse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thrombose veineuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2026-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thrombose",
"url": "https://questionsmedicales.fr/mesh/D013927",
"about": {
"@type": "MedicalCondition",
"name": "Thrombose",
"code": {
"@type": "MedicalCode",
"code": "D013927",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.830"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Budd-Chiari",
"alternateName": "Budd-Chiari Syndrome",
"url": "https://questionsmedicales.fr/mesh/D006502",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Budd-Chiari",
"code": {
"@type": "MedicalCode",
"code": "D006502",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.830.925.275"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thrombose veineuse profonde du membre supérieur",
"alternateName": "Upper Extremity Deep Vein Thrombosis",
"url": "https://questionsmedicales.fr/mesh/D056824",
"about": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse profonde du membre supérieur",
"code": {
"@type": "MedicalCode",
"code": "D056824",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.830.925.885"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse",
"alternateName": "Venous Thrombosis",
"code": {
"@type": "MedicalCode",
"code": "D020246",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Diana Aguiar de Sousa",
"url": "https://questionsmedicales.fr/author/Diana%20Aguiar%20de%20Sousa",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Neurologia, Department of Neurosciences and Mental Health, Centro Hospitalar Lisboa Norte, Instituto de Medicina Molecular, Lisbon, Portugal."
}
},
{
"@type": "Person",
"name": "José M Ferro",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20M%20Ferro",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Neurologia, Department of Neurosciences and Mental Health, Centro Hospitalar Lisboa Norte, Instituto de Medicina Molecular, Lisbon, Portugal. jmferro@medicina.ulisboa.pt."
}
},
{
"@type": "Person",
"name": "Mirjam R Heldner",
"url": "https://questionsmedicales.fr/author/Mirjam%20R%20Heldner",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Neurology (L.S., C.S., N.K., S.E., A.C., S.C., F.I., K.F., Shadi Yaghi), Brown University, Providence, RI; Department of Neurology (E.B.), University of Alabama at Birmingham; Department of Neurology (S.S.O.), University of Colorado School of Medicine, Aurora; Department of Neurology (J.G., J.A.), Washington University, Saint Louis, MO; Departments of Neurology (N.H., M.D.M.), and Psychiatry (N.H.), University of Massachusetts, Worcester; Department of Neurology (A.L.), Weill Cornell Medical Center, New York, NY; Department of Neurology (K.M., J.R.), Montefiore Medical Center, New York, NY; Department of Neurology (R.S., Yee Cheng, A.S.Z., A.H.), Yale University, New Haven, CT; Department of Neurology (Alexis Simpkins, G.L., J.K., D.P.), University of Florida, Gainesville; Department of Neurology (M.R.H., Adrian Scutelnic, R.M., B.S.), Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland; Department of Neurology (A.R., O.K., D.D.), University of Pennsylvania, Philadelphia; Departments of Neurology (S.A.K., L.A.R.) and Neurosurgery (S.A.K.), Medical University of South Carolina, Charleston; Department of Neurology and Rehabilitation Medicine (E.A.M., Pooja Khatri, Y.A., B.C.), University of Cincinnati; Department of Neurology (D.K., H.L.), Vanderbilt University, Nashville, TN; Department of Neurology (T.N.N., Piers Klein, H.J.A.), Boston University School of Medicine, MA; Department of Neurology (J.A.F., L.K., S.A.), New York University, NY; Department of Neurology (V.M.), University of Utah, Salt Lake City; Department of Neurology (T.W., D.W.), Christchurch Hospital, New Zealand; Department of Neurology (A.N., D.A.), Hartford Hospital, CT; Department of Neurology (A.Q., J.M.), University of Kansas, Kansas City; Department of Neurology (M.K., Yao Cheng), Spectrum Health, Michigan State University, Grand Rapids, MI; Department of Neurology (B.M.G., M.W., D.R.), Duke University, Durham, NC; Department of Medicine and Surgery (M.C.V.), University of Perugia, Italy, University of Perugia, Italy; Neurology-Stroke Unit (Maurizio Paciaroni), IRCCS MultiMedica, Milano, Italy; Cooper Neurologic Institute (J.S., S.K., Siyuan Yu), Cooper University, Camden, NJ; Department of Neurology (C.L.G., E.A.), George Washington University, District of Columbia; Department of Neurology (G.M.D.M., T.D.), University Hospital Basel and University of Basel, Switzerland; Department of Interventional and Diagnostic Neuroradiology (A.B., Marios Psychogios), Clinic of Radiology and Nuclear Medicine, University Hospital Basel and University of Basel, Switzerland; Department of Neurology (R.A.-D., T.K.-H., S.P.), University of Chicago, IL; and Department of Neurology (T.H., D.L.), University of California at Los Angeles."
}
},
{
"@type": "Person",
"name": "Erik Lindgren",
"url": "https://questionsmedicales.fr/author/Erik%20Lindgren",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden."
}
},
{
"@type": "Person",
"name": "Sini Hiltunen",
"url": "https://questionsmedicales.fr/author/Sini%20Hiltunen",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Pulmonary venous thrombosis in a healthy pregnancy.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38937266",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2024-259773"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perfusion MRI in Cerebral Venous and Sinus Thrombosis.",
"datePublished": "2024-08-31",
"url": "https://questionsmedicales.fr/article/39216035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/neurol-india.NI_485_20"
}
},
{
"@type": "ScholarlyArticle",
"name": "The incidence of deep venous thrombosis in Parkinson's disease.",
"datePublished": "2023-09-12",
"url": "https://questionsmedicales.fr/article/37699515",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01616412.2023.2257441"
}
},
{
"@type": "ScholarlyArticle",
"name": "Venous Interventions: Controversies in the Management of Acute Deep Venous Thrombosis and the Role of the Interventional Radiologist.",
"datePublished": "2024-05-25",
"url": "https://questionsmedicales.fr/article/39393846",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.rcl.2024.04.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cerebral venous thrombosis (CVT) complicating tubercular meningitis.",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37355584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12883-023-03286-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Embolie et thrombose",
"item": "https://questionsmedicales.fr/mesh/D016769"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thrombose",
"item": "https://questionsmedicales.fr/mesh/D013927"
},
{
"@type": "ListItem",
"position": 6,
"name": "Thrombose veineuse",
"item": "https://questionsmedicales.fr/mesh/D020246"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thrombose veineuse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thrombose veineuse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thrombose veineuse",
"description": "Comment diagnostiquer une thrombose veineuse ?\nQuels tests sanguins sont utilisés ?\nQuels signes cliniques indiquent une thrombose ?\nL'IRM est-elle utile pour le diagnostic ?\nQuand faut-il suspecter une thrombose veineuse ?",
"url": "https://questionsmedicales.fr/mesh/D020246#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thrombose veineuse",
"description": "Quels sont les symptômes d'une thrombose veineuse ?\nLa douleur est-elle toujours présente ?\nPeut-on avoir de la fièvre avec une thrombose ?\nLes symptômes varient-ils selon l'emplacement ?\nY a-t-il des symptômes systémiques ?",
"url": "https://questionsmedicales.fr/mesh/D020246#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thrombose veineuse",
"description": "Comment prévenir la thrombose veineuse ?\nLes voyages prolongés augmentent-ils le risque ?\nLes anticoagulants préventifs sont-ils recommandés ?\nQuelles sont les recommandations post-chirurgicales ?\nL'obésité est-elle un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D020246#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thrombose veineuse",
"description": "Quels traitements sont disponibles pour la thrombose ?\nLes anticoagulants sont-ils toujours nécessaires ?\nQu'est-ce que la thrombolyse ?\nLes bas de compression sont-ils efficaces ?\nQuand est-il nécessaire d'hospitaliser un patient ?",
"url": "https://questionsmedicales.fr/mesh/D020246#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thrombose veineuse",
"description": "Quelles complications peuvent survenir ?\nQu'est-ce que le syndrome post-thrombotique ?\nL'embolie pulmonaire est-elle grave ?\nComment prévenir les complications ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D020246#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thrombose veineuse",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme augmente-t-il le risque ?\nLes femmes enceintes sont-elles à risque ?\nL'âge est-il un facteur de risque ?\nLes maladies chroniques influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D020246#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une thrombose veineuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen clinique, une échographie Doppler et des tests sanguins sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dosage du D-dimère est courant pour évaluer la présence d'un caillot."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une thrombose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleur, gonflement, rougeur et chaleur dans la zone affectée sont des signes clés."
}
},
{
"@type": "Question",
"name": "L'IRM est-elle utile pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IRM peut aider à visualiser les thromboses dans les veines profondes."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une thrombose veineuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de douleur soudaine et de gonflement d'un membre, une évaluation est nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une thrombose veineuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement, rougeur et chaleur au site de la thrombose."
}
},
{
"@type": "Question",
"name": "La douleur est-elle toujours présente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la douleur peut être absente, surtout dans les cas de thrombose asymptomatique."
}
},
{
"@type": "Question",
"name": "Peut-on avoir de la fièvre avec une thrombose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une légère fièvre peut survenir, mais ce n'est pas un symptôme courant."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'emplacement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer selon que la thrombose est superficielle ou profonde."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme l'essoufflement peuvent indiquer une embolie pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la thrombose veineuse ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité physique régulière, l'hydratation et le port de bas de compression aident."
}
},
{
"@type": "Question",
"name": "Les voyages prolongés augmentent-ils le risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, rester assis longtemps peut favoriser la formation de caillots sanguins."
}
},
{
"@type": "Question",
"name": "Les anticoagulants préventifs sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent prescrits aux patients à risque élevé, comme après une chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations post-chirurgicales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mobilisation précoce et utilisation de bas de compression sont recommandées."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité augmente le risque de thrombose veineuse en raison de la pression sur les veines."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la thrombose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants, les bas de compression et parfois la thrombolyse sont utilisés."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils toujours nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont essentiels pour prévenir l'extension du caillot et les complications."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thrombolyse ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement qui utilise des médicaments pour dissoudre les caillots sanguins."
}
},
{
"@type": "Question",
"name": "Les bas de compression sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à réduire le gonflement et à améliorer la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quand est-il nécessaire d'hospitaliser un patient ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de thrombose massive ou de complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'embolie pulmonaire, le syndrome post-thrombotique et la douleur chronique."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le syndrome post-thrombotique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une condition chronique causée par des dommages aux veines après une thrombose."
}
},
{
"@type": "Question",
"name": "L'embolie pulmonaire est-elle grave ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, c'est une complication potentiellement mortelle nécessitant une intervention rapide."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et une surveillance régulière aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent survenir dans 20 à 30 % des cas de thrombose veineuse profonde non traitée."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immobilisation, l'obésité, les antécédents familiaux et la chirurgie."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour la thrombose veineuse."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la grossesse augmente le risque de thrombose en raison des changements hormonaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de thrombose augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme le cancer et les maladies cardiaques augmentent le risque."
}
}
]
}
]
}
Serviço de Neurologia, Department of Neurosciences and Mental Health, Centro Hospitalar Lisboa Norte, Instituto de Medicina Molecular, Lisbon, Portugal.
Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz s/n, 1649-035, Lisbon, Portugal.
Serviço de Neurologia, Department of Neurosciences and Mental Health, Centro Hospitalar Lisboa Norte, Instituto de Medicina Molecular, Lisbon, Portugal. jmferro@medicina.ulisboa.pt.
Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz s/n, 1649-035, Lisbon, Portugal. jmferro@medicina.ulisboa.pt.
From the Department of Neurology (L.S., C.S., N.K., S.E., A.C., S.C., F.I., K.F., Shadi Yaghi), Brown University, Providence, RI; Department of Neurology (E.B.), University of Alabama at Birmingham; Department of Neurology (S.S.O.), University of Colorado School of Medicine, Aurora; Department of Neurology (J.G., J.A.), Washington University, Saint Louis, MO; Departments of Neurology (N.H., M.D.M.), and Psychiatry (N.H.), University of Massachusetts, Worcester; Department of Neurology (A.L.), Weill Cornell Medical Center, New York, NY; Department of Neurology (K.M., J.R.), Montefiore Medical Center, New York, NY; Department of Neurology (R.S., Yee Cheng, A.S.Z., A.H.), Yale University, New Haven, CT; Department of Neurology (Alexis Simpkins, G.L., J.K., D.P.), University of Florida, Gainesville; Department of Neurology (M.R.H., Adrian Scutelnic, R.M., B.S.), Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland; Department of Neurology (A.R., O.K., D.D.), University of Pennsylvania, Philadelphia; Departments of Neurology (S.A.K., L.A.R.) and Neurosurgery (S.A.K.), Medical University of South Carolina, Charleston; Department of Neurology and Rehabilitation Medicine (E.A.M., Pooja Khatri, Y.A., B.C.), University of Cincinnati; Department of Neurology (D.K., H.L.), Vanderbilt University, Nashville, TN; Department of Neurology (T.N.N., Piers Klein, H.J.A.), Boston University School of Medicine, MA; Department of Neurology (J.A.F., L.K., S.A.), New York University, NY; Department of Neurology (V.M.), University of Utah, Salt Lake City; Department of Neurology (T.W., D.W.), Christchurch Hospital, New Zealand; Department of Neurology (A.N., D.A.), Hartford Hospital, CT; Department of Neurology (A.Q., J.M.), University of Kansas, Kansas City; Department of Neurology (M.K., Yao Cheng), Spectrum Health, Michigan State University, Grand Rapids, MI; Department of Neurology (B.M.G., M.W., D.R.), Duke University, Durham, NC; Department of Medicine and Surgery (M.C.V.), University of Perugia, Italy, University of Perugia, Italy; Neurology-Stroke Unit (Maurizio Paciaroni), IRCCS MultiMedica, Milano, Italy; Cooper Neurologic Institute (J.S., S.K., Siyuan Yu), Cooper University, Camden, NJ; Department of Neurology (C.L.G., E.A.), George Washington University, District of Columbia; Department of Neurology (G.M.D.M., T.D.), University Hospital Basel and University of Basel, Switzerland; Department of Interventional and Diagnostic Neuroradiology (A.B., Marios Psychogios), Clinic of Radiology and Nuclear Medicine, University Hospital Basel and University of Basel, Switzerland; Department of Neurology (R.A.-D., T.K.-H., S.P.), University of Chicago, IL; and Department of Neurology (T.H., D.L.), University of California at Los Angeles.
We describe an unusual case of bilateral pulmonary venous thrombosis in a pregnant woman in her mid 30s, who presented at 34 weeks of gestation with symptoms of sudden onset chest pain, shortness of b...
Cerebral venous and sinus thrombosis (CVST) leads to perfusion abnormality in the brain. Our aim was to assess perfusion abnormalities in the center and periphery of the parenchymal lesion in CVST pat...
Dynamic susceptibility contrast (DSC) perfusion imaging was performed in patients with CVST. Relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and mean transit time (MTT) val...
A total of 30 consecutive patients of CVST were included in the study. Parenchymal lesion was present in 21 (70%) patients. In rest 9, perfusion map was showing some abnormality although conventional ...
There is an increasing trend of MTT and rCBV from periphery to center of the parenchymal lesion. MTT is the most consistent parameter to be abnormal in patients of CVST even in patients without parenc...
Venous thromboembolism is one of the causes of sudden death in Parkinson's Disease (PD). Few studies have investigated the correlation between PD and deep venous thrombosis (DVT). This study aimed to ...
Demographic characteristics of 37 PD patients without known risk factors for DVT, disease duration, Hoehn-Yahr (H - Y) stage, oxygen saturation (SpO2) and heart rate values with pulse oximetry, use of...
With the H-Y stage of the disease duration, a positive correlation was determined between the H-Y stage and mMRC. Disease duration was negatively correlated with BMI and positively correlated with the...
Attention should be paid to the development of DVT in elderly patients with advanced stages of PD, progression in the H-Y stage, use of assistive devices, and progression in dyspnea scoring. There is ...
Lower extremity deep venous thrombosis (DVT) is estimated to occur in 1 in 1000 persons annually in adult populations, with prevalence predicted to double by the year 2050. While acute DVT and pulmona...
Tuberculous meningitis (TBM), complicated with cerebral venous thrombosis (CVT), has been sparsely reported and needs to be investigated further....
Among those with tuberculous meningitis in Haihe Hospital, Tianjin University, 3 patients with venous sinus thrombosis were identified retrospectively. "Tuberculous meningitis" and "cerebral venous th...
Among 28 patients with a median onset age of 31 years for TBM, 17 were females. The manifestations were fever, headache, and seizure. Magnetic resonance imaging (MRI) venography showed that the most c...
CVT is one of the rare complications of TMB and must be considered a differential diagnosis in patients with TBM who show poor clinical features and/or develop new neurological signs....
Superficial venous thrombosis (SVT) is a fairly common disorder, characterized by the formation of thrombi inside superficial veins, with or without an associated inflammatory reaction. Its evolution ...
Cerebral sinus venous thrombosis (CSVT) is an uncommon condition in children with potentially serious outcomes. Large epidemiological studies in children with CSVT are few. The objective of this study...
We performed a retrospective cross-sectional analysis of the Healthcare Cost and Utilization Project Kids' Inpatient Database for the combined years 2016 and 2019. The database was queried using the d...
Of 12,165,621 discharges, 3202 had CSVT (in-hospital prevalence 26.3 per 100,000 discharges). Male patients accounted for 57% of CSVT discharges. The median age was 8 years (interquartile range 1-16),...
CSVT, which has a U-shaped age distribution, is an uncommon condition in children. Stroke is common in children with CSVT, and it is associated with an increased need for mechanical ventilation and in...
A subset of patients with superficial venous thrombosis (SVT) experiences clot propagation towards deep venous thrombosis (DVT) and/or pulmonary embolism (PE). The aim of this systematic review is to ...
Systematic review....
PubMed/MEDLINE and Embase were systematically searched until 3 March 2023....
Original research studies with patients with SVT, DVT and/or PE as the outcome and presenting cross-sectional or prognostic predictive factors....
The CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling (CHARMS) checklist for prognostic factor studies was used for systematic extraction of study cha...
Twenty-two studies were included (n=10 111 patients). The most reported predictive factors were high age, male sex, history of venous thromboembolism (VTE), absence of varicose veins and cancer. Poole...
Although the pooled estimates of the predictors high age, male sex, history of VTE, cancer and absence of varicose veins showed predictive potential in isolation, variability in study designs, lack of...
CRD42021262819....
Emerging data suggest that direct oral anticoagulants may be a suitable choice for anticoagulation for cerebral venous thrombosis (CVT). However, conducting high-quality trials in CVT is challenging a...
This was a phase II, prospective, open-label blinded-end point 1:1 randomized trial conducted at 12 Canadian centers. Participants were aged ≥18 years, within 14 days of a new diagnosis of symptomatic...
Fifty-five participants were randomized. The rate of recruitment was 21.3 participants/year; 57% of eligible candidates consented. Median age was 48.0 years (interquartile range, 38.5-73.2); 66% were ...
Recruitment targets were reached, but many eligible participants declined randomization. There were numerically more bleeding events in patients taking rivaroxaban compared with control, but rates of ...
URL: https://www....
gov; Unique identifier: NCT03178864....
Cancer-associated venous thromboembolism (CAT) poses a severe threat, disrupting ongoing cancer management and adversely impacting treatment outcomes. CAT often leads to a two- to six-fold increase in...
